Michael Curtin,Michael R. Michaelides,Howard Robin Heyman,Robin Frey
申请号:
US12796751
公开号:
US08426408B2
申请日:
2010.06.09
申请国别(地区):
US
年份:
2013
代理人:
摘要:
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts,wherein A1, A2, A3, A4, X and Y are defined in the description. The present invention relates also to methods of making said compounds, and compositions containing said compounds which are useful for inhibiting kinases such as aurora and KDR.